The global active implantable medical devices market was valued at USD 26.78 billion in 2021, growing at a CAGR of 7.63% during the forecast period from 2022 to 2027, to reach USD 41.47 billion by 2027. The rise in demand for active implantable medical devices is primarily attributed to the growing burden of various diseases such as neurological disorders, cardiovascular disorders, hearing disability, and others among the worldwide population due to the growing old age population. In addition, rise in product approvals, and increase in investment and funds by the companies for the development of active implantable devices, among others are also the factors responsible for the global active implantable medical devices market growth during the forecasted period.
Active Implantable Medical Devices
An active implantable medical device (AIMD) is a medical device intended to be totally or partially introduced into the human body for diagnostic or therapeutic purposes and is to remain in place. It includes a wide range of devices, including pacemakers, defibrillators, infusion pumps, ventricular assist systems and devices, cochlear implants, and neurostimulators.
Download Sample Report- https://www.delveinsight.com/sample-request/active-implantable-medical-devices-market
Recent Developmental Activities in the Active Implantable Medical Devices Market:
Key Takeaways from the Active Implantable Medical Devices Market Report Study
COVID19 Impact on the Active Implantable Medical Devices Market
Also, the unprecedented COVID-19 outbreak has impacted the global active implantable medical devices market during the initial phases. This is owing to the nationwide lockdown, cancelled or postponed surgeries, and patient reluctance to visit the hospitals, among others. However, due to the launch of various vaccines and mass vaccination drives across the globe the market for active implantable devices is expected to regain normalcy in the post-COVID situation.
Active Implantable Medical Devices Market Dynamics
The demand for various active implantable devices is gaining momentum at present owing to the rising prevalence of disorders majorly associated with heart and brain among the old age population across the globe. According to the United Nations Department of Economic and Social affairs 2020 highlights, worldwide, there were an estimated 727 million persons aged 65 years and over in the year 2020 which is projected to double and reach over 1.5 billion persons by the year 2050. The senescing population is more likely to develop various chronic disorders. For instance, as per the statistics revealed by the World Health Organization (WHO) in the year 2021, above 5% of the world’s population which is approximately 430 million people are suffering from hearing disability, and the prevalence of hearing loss increases with age affecting over 25% population older than 60 years are affected by disabling hearing loss.
Active Implantable Medical Devices Market Segment Analysis
Active Implantable Medical Devices Product Segment
The implantable neurostimulation product segment is anticipated to hold a noteworthy market share in the forthcoming years. This is due to the exponentially growing cases of neurological disorders and nerve-associated disorders such as epilepsy, migraine, Parkinson’s disease, and others among the population across the globe. According to the WHO stats published in the year 2019, approximately 50 million people worldwide have epilepsy, making it one of the most common neurological diseases globally.
Active Implantable Medical Devices Market Companies
Some of the key market players operating in the Active Implantable Medical Devices market include Medtronic, ABIOMED., Abbott, Jarvik Heart, Inc., Biotronik SE & Co. KG, Boston Scientific Corporation, LivaNova, Inc., MicroTransponder Inc., Axonics Modulation Technologies, Inc., MED-EL Medical Electronics, Second Sight, NeuroPace, Inc., NEVRO CORP., Pacetronix.com, MEDICO S.p.A., Aleva Neurotherapeutics S.A., Cochlear Ltd., Sonova, Berlin Heart GmbH, and SynCardia Systems LLC, among others.
Request Sample Report- https://www.delveinsight.com/sample-request/active-implantable-medical-devices-market
Table of Content
1. Active Implantable Medical Devices Market Report Introduction
2. Active Implantable Medical Devices Market Executive summary
3. Regulatory and Patent Analysis
4. Active Implantable Medical Devices Market Key factors analysis
5. Active Implantable Medical Devices Porter’s Five Forces Analysis
6. COVID-19 Impact Analysis on Active Implantable Medical Devices Market
7. Active Implantable Medical Devices Market layout
8. Active Implantable Medical Devices Global Company Share Analysis – Key 3-5 Companies
9. Active Implantable Medical Devices Company and Product Profiles
10. KOL Views
11. Project Approach
12. About DelveInsight
13. Disclaimer & Contact Us
About Us
DelveInsight is a Business Consulting and Market research company, providing expert business solutions for the healthcare domain and offering quintessential advisory services in the areas of R&D, Strategy Formulation, Operations, Competitive Intelligence, Competitive Landscaping, and Mergers & Acquisitions.
Media ContactCompany Name: DelveInsightContact Person: YashEmail: Send EmailPhone: +919650213330Address:304 S. Jones Blvd #2432 City: AlbanyState: New YorkCountry: United StatesWebsite: https://www.delveinsight.com/